Compositions and methods for evaluating genomic alterations
AssigneeFoundation Medicine, Inc.
InventorsGeoffrey Alan Otto, Travis Clark, Doron Lipson, Daniel Lieber, David Fabrizio
Life of this patent
Estimating the term…
Abstract
Compositions and methods of evaluating genomic alterations in a sample are disclosed.
Claims23
A plurality of target capture reagents, comprising first target capture reagents (R1s), wherein each R1 comprises an oligonucleotide comprising a first nucleic acid sequence that hybridizes to a first target nucleic acid sequence, wherein the oligonucleotides of the R1s are the same, and second target capture reagents (R2s), wherein each R2 comprises an oligonucleotide comprising a second nucleic acid sequence that hybridizes to a second target nucleic acid sequence, wherein the oligonucleotides of the R2s are the same, wherein:
- a first portion of the R1s comprises a first member of a binding pair;
- a second portion of the R1s lacks the first member of the binding pair;
- a first portion of the R2s comprises the first member of the binding pair;
- and
- a second portion of the R2s lacks the first member of the binding pair;
- wherein the first member of the binding pair binds a second member of the binding pair disposed on a substrate, and
- wherein the proportion of R1s that comprises the first member of the binding pair is greater than the proportion of R2s that comprise the first member of the binding pair.
Dependencies are inferred from the claim text.